U.S. Molecular Biology Enzymes, Reagents And Kits Market Size & Outlook
U.S. molecular biology enzymes, reagents and kits market, 2018-2030 (US$M)
Related Markets
U.S. molecular biology enzymes, reagents and kits market highlights
- The U.S. molecular biology enzymes, reagents and kits market generated a revenue of USD 8,508.3 million in 2022 and is expected to reach USD 18,017.3 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.8% from 2023 to 2030.
- In terms of segment, kits & reagents was the largest revenue generating product in 2022.
- Enzymes is the most lucrative product segment registering the fastest growth during the forecast period.
Molecular biology enzymes, reagents and kits market data book summary
| Market revenue in 2022 | USD 8,508.3 million |
| Market revenue in 2030 | USD 18,017.3 million |
| Growth rate | 9.8% (CAGR from 2022 to 2030) |
| Largest segment | Kits & reagents |
| Fastest growing segment | Enzymes |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Kits & Reagents, Enzymes |
| Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Agilent Technologies Inc, Qiagen NV, New England Biolabs, Merck KGaA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Takara Bio Inc, LGC Group, Bausch Health Companies Inc, Promega |
Other key industry trends
- In terms of revenue, U.S. accounted for 40.6% of the global molecular biology enzymes, reagents and kits market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. molecular biology enzymes, reagents and kits market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 2,564.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Molecular Biology Enzymes, Reagents And Kits Market Scope
Molecular Biology Enzymes, Reagents And Kits Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. molecular biology enzymes, reagents and kits market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular biology enzymes, reagents and kits market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 67.62% in 2022. Horizon Databook has segmented the U.S. molecular biology enzymes, reagents and kits market based on kits & reagents, enzymes covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. accounted for the major revenue share of North America market in 2019. Increasing application of NGS technology coupled with developments in PCR tools is anticipated to positively impact the market growth. Development of technologically advanced products is also contributing to the market growth.
For instance, in May 2019, Pharmozyme, Inc. launched Crystal Taq, which is a costeffective solution with improved test accuracy. This is the first Taq Polymerase enzyme free from bacterial and animal DNA contamination. This product reduces PCR background contamination. Furthermore, rise in government initiatives to promote precision medicine is expected to result in lucrative growth.
The National Institute of Health along with various other research institutes is engaged in precision medicine initiative. The NIH had also launched All of Us Research Program in 2015 aimed to gather genetic data from participants to develop precision medicine for all health conditions.
Reasons to subscribe to U.S. molecular biology enzymes, reagents and kits market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. molecular biology enzymes, reagents and kits market databook
-
Our clientele includes a mix of molecular biology enzymes, reagents and kits market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. molecular biology enzymes, reagents and kits market , including forecasts for subscribers. This country databook contains high-level insights into U.S. molecular biology enzymes, reagents and kits market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. molecular biology enzymes, reagents and kits market size, by product, 2018-2030 (US$M)
U.S. Molecular Biology Enzymes, Reagents And Kits Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
